Aldo Di Costanzo Mata, Head of the Gluckli Project

Preterm infants are uniquely at risk due to a lack of glucose deposits in their tissue compared to full-term infants. However, monitoring blood glucose is currently only possible by taking blood samples - a process limited to once per several hours due to their low blood volume.

The Gluckli Project hopes to make a substantial difference for at-risk preterm infants. The Gluckli team is developing a non-invasive tool to continuously monitor blood glucose levels of preterm infants using microfluidics technology.

The Gluckli project is based out of the University of Zurich and University Hospital Zurich, and led by Dr Aldo Di Costanzo Mata, an Entrepreneur Fellow at the University of Zurich. He talks to us about his journey from Mexico to Switzerland and becoming a founder.